Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 ...

Diabetic retinopathy screening with AI was associated with higher referral rates to optical coherence tomography but remains underutilized.

Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with ...

Southern United States residents have a higher risk of diabetic retinopathy, as do those with less education and lower ...

This project uses MobileNetV2 to detect Diabetic Retinopathy (DR) and classify its severity. It supports binary (DR vs. No DR) and multiclass (Mild, Moderate, Proliferative_DR, Severe) classifications ...

Despite its underutilization, AI-powered diabetic retinopathy screening was associated with greater OCT referral rates than traditional screening methods. Artificial intelligence (AI)-based ...

OCX-063 is under clinical development by OccuRx and currently in Phase I for Diabetic Retinopathy. According to GlobalData, Phase I drugs for Diabetic Retinopathy have a 78% phase transition success ...